PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24310825-3 2014 METHODS: We report four pediatric patients with various malignancies (chronic myelogenous leukemia, acute lymphoblastic leukemia, and glioma/renal cell carcinoma) who developed nephrotic syndrome during treatment with TK inhibitors (imatinib, sunitinib, dasatinib, and quizartinib). quizartinib 269-280 TXK tyrosine kinase Homo sapiens 218-220